Summary
This prediction ended on 11.11.22 with a price of €7.20. BiotechBee correctly predicted massive losses of -38.34% for Veru Inc. BiotechBee has a follow-up prediction for Veru Inc, but this time predicts that Veru Inc is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Veru Inc | -0.057% | -0.057% | -19.112% |
iShares Core DAX® | 0.039% | 0.567% | 12.281% |
iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% |
iShares Nikkei 225® | -2.389% | -1.434% | 8.335% |
iShares S&P 500 | -2.115% | -2.351% | 22.061% |
According to BiotechBee what are the pros and cons of Veru Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Veru Inc diskutieren
Sell mit Kursziel 7,0
In the thread Trading Veru Inc
Sell beendet